Press Releases
Saluda Medical Expands Access to First and Only FDA-Approved Closed-Loop Surgical Paddle Lead with Full US Commercial Release of CAP24™
October 6, 2026
Read More
Saluda Medical Receives U.S. FDA Approval for New CAP24™ Surgical Paddle Lead
Minneapolis, United States
June 30, 2026
Read More
Saluda Medical Receives Regulatory Approval for EVA™ Sensing Technology in Europe with recognition in Australia
Minneapolis, United States
January 8, 2026
Read More
Saluda Medical Announces Full U.S. Launch of EVA™ Sensing Technology for Use with the Evoke® SmartLoop™ System
Minneapolis, United States
July 17, 2025
Read More
Saluda Medical Appoints Barry Regan as Chief Executive Officer
Minneapolis, United States
June 30, 2025
Follows the Addition of Mike Mathias as Chief Commercial Officer in Late 2024 and Jim Erickson as Chief Financial Officer in Late 2023
Read More
Saluda Medical Announces Presentation of New Clinical Data at the 2025 NANS Annual Meeting
Minneapolis, United States
February 7, 2025
Read More
For more information, please contact:
Investor and Media Contact:
Sam Wells
NWR Communications
+61 (0) 427 630 152
sam@nwrcommunications.com.au